{"id":"NCT00861614","sponsor":"Bristol-Myers Squibb","briefTitle":"Study of Immunotherapy to Treat Advanced Prostate Cancer","officialTitle":"A Randomized, Double-Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects With Castration Resistant Prostate Cancer That Have Received Prior Treatment With Docetaxel","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05","primaryCompletion":"2012-11","completion":"2015-08","firstPosted":"2009-03-13","resultsPosted":"2016-03-16","lastUpdate":"2016-09-30"},"enrollment":988,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Ipilimumab","otherNames":["BMS 734016"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ipilimumab","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to determine if advanced prostate cancer patients that are treated with radiotherapy (RT) plus ipilimumab live longer that those treated with RT alone","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"Date of randomization to date of death","effectByArm":[{"arm":"Ipilimumab + Radiotherapy","deltaMin":11.04,"sd":null},{"arm":"Placebo + Radiotherapy","deltaMin":10.02,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0127"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":158,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","Chile","Colombia","Czechia","Denmark","France","Germany","Greece","Hungary","Ireland","Israel","Italy","Mexico","Netherlands","Peru","Poland","Puerto Rico","Romania","Russia","Spain","United Kingdom"]},"refs":{"pmids":["25907621","24831977","21917607"],"seeAlso":["http://www.bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":257,"n":393},"commonTop":["Diarrhoea","Fatigue","Nausea","Decreased appetite","Vomiting"]}}